chrisvoncsefalvay/vaers-outcomes huggingface dataset:
c/o scratch throat and itching at Rt cheekbone and around lt eye. Itching progressed to head and arms, head felt swollen and throat felt tight. Saw an MD who gave her a cortisone injection and prednisone tabs.
patient reported pain in her hips with direct onset at the time of vaccination, trouble walking. called EMS, took her BP which was 207/110 mmHg. Upon their arrival, her BP had come down a bit, and she reported no pain and was able to walk but because of her BP they wanted her to been taken into the hospital.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a 24-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 01-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  No treatment information was provided.
Fever of 101.4, chills, muscle aches, joint aches, headache, nauseous, light-headedness.
Information has been received from a healthcare professional through a Pregnancy Registry for GARDASIL concerning a 17 year old female with depression, attention deficit disorder, obsessive compulsive disorder and post-traumatic stress disorder who on 20-FEB-2008, 21-APR-2008 and 26-AUG-2008 was vaccinated with the first, second and third dose of GARDASIL, the second dose on 21-APR-2008 and third dose on 26-AUG-2008 (lot#s 659653/1448U, unidentifiable and 660620/0571X respectively). Concomitant therapies included ABILIFY, PROZAC and TRILEPTAL. The patient's last menstrual period was reported as 08-AUG-2009, EDD: 15-MAY-2009. Follow up information was received from nurse in physician's office via a phone call who reported the patient had a termination in November 2008. The patient was doing fine and there was no sequelae from the vaccination. Upon internal review, a termination (abortion) was determined to be an other important medical event. Additional information has been requested.
1) Bruise on right shoulder (opposite shoulder from injection) 2) Nosebleed - lasted approximate 5 mins, 2 Kleenexes, only once  3) Bruise on left leg (large ~ 2 inches in diameter, white center)
Patient presented to pharmacy on 7/24 and showed a left arm that was swollen and red all the way down to the left elbow and all the way around the arm. Patient stated that he had feelings of numbness in his left hand the night before and his whole arm was very hot to the touch. He was instructed to take Benadryl and seek out medical help if the condition got any worse.
Information has been received from a published article, title as stated above. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient #4 of 32, a 52 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 52 year old female on an unspecified date was vaccinated with her first dose of RECOMBIVAX HB (lot number, route and site not reported). There was no concomitant medication. One day after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327, 1004USA02328, WAES # 1004USA02330 to WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
having tingling to her in face 2 days after receiving the first dose and is ongoing; This is a spontaneous report from a contactable consumer (patient, self-reported). A 54-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 25May2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that on 27May2021, she began having tingling to her in face 2 days after receiving the first dose and was ongoing. The patient was scheduled to have the second dose on 15Jun2021 and wanted to know if she should take the second dose of the vaccine. The response included that as the prescribing information did not include all adverse reactions that have been reported or that may occur, please consulted with your doctor/healthcare provider about what you have experienced/were experiencing and because your doctor/healthcare provider was most familiar with your medical condition, clinical history, how your treatment has been conducted and any relevant information to your specific case, your doctor/healthcare provider was in the best position to advise you about the appropriate action to take. Outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Beginning 02/10 - Cognitive Fog. Word finding difficulty, repeating same question. Not able to keep up with work charting like normal, difficulty concentrating.  02/16 - awoken with headache encompassing entire head, numbness in left lower lip that lasted most of the day.   I continue to be in a brain fog with difficulty completing tasks and continued  word finding difficulty.
Severe increase in migraine headaches post vaccine. Saw neurologist. Changed abortive medication. Added nausea medication. Still struggling with uncontrolled headaches.
No adverse event; Received a booster dose of Monovalent Moderna COVID-19 vaccine instead of Bivalent booster; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Received a booster dose of Monovalent Moderna COVID-19 vaccine instead of Bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Received a booster dose of Monovalent Moderna COVID-19 vaccine instead of Bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Received a booster dose of Monovalent Moderna COVID-19 vaccine instead of Bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Received a booster dose of Monovalent Moderna COVID-19 vaccine instead of Bivalent booster).    No concomitant medication was reported.    No treatment information was reported.  The patient received a booster dose of monovalent Moderna COVID-19 vaccine instead of Bivalent booster.  Patient does not have the lot information.
Mom states that she noticed the reaction on the morning of 7/18. Mom states that she did 2 days of Benadryl and hydrocortisone cream. Still red and swollen,  it's itchy.
Patient complained of itching at the injection site. Redness was noted at the injection site. The event occurred approx 10 minutes after the patient received the vaccine. The MD evaluated the patient.
This non-serious medically confirmed report (initial receipt 17-Oct-2014) concerns a one year old female patient. The patient's daycare centre reported a possible case of chickenpox in another child attending daycare. On the 07-Oct-2014, the patient received an unspecified influenza vaccine (manufacturer and batch number not reported), HAVRIX (batch number not reported), MMR II (batch number not reported) and VARIVAX (batch number not reported) 0.5mL via the subcutaneous route for vaccination. On the 08-Oct-2014, the patient developed two red raised bumps on her face. On the 09-Oct-2014, the patient developed one raised red bump on her chest. Outcome was not recovered.
DIZZINESS; This spontaneous report received from a patient concerned a 52 year old male. The patient's weight was 410 pounds, and height was not reported. The patient's past medical history included meneires disease, and other pre-existing medical conditions included the patient's family has cancer, atrial fibrillation (mother), and glaucoma (mother).The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 206H21A expiry: UNKNOWN) dose was not reported, administered on 07-MAY-2021 09:20 for prophylactic vaccination. No concomitant medications were reported. On 07-MAY-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness. This report was non-serious.
Developed hives and soreness in shoulder and arm. No hot to touch or swelling in right arm et. shoulder where PNEUMOVAX was given.
Received phone call yesterday from patient (2/11/15) reported her (L) arm really red and swollen-told her she could try ice packs (cold compresses) if worse to to see MD-Let me know if went-APN notified us she had seen patient in clinic office.
Started with slight headache with shot. The next day started to become tired and irritable progressing that evening to hand/leg twitches and couldn't sleep. Morning of second day had congested sinuses, occasional sneezing, slight fever, cold hands and feet, fatigue, trouble breathing with a tight chest feeling, and light-headed.
Knee pain; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer, the patient, reported that a 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EL8982, first dose) solution for injection intramuscular on 27Jan2021 (at the age of 70-years-old) at single dose for COVID-19 vaccination. There was no medical history. There were no concomitant medications. The patient experienced knee pain after the first vaccine in 2021 and her orthopedic doctor recommended an oral steroid for 6 days. The patient had a knee procedure (unrelated to vaccine) and was prescribed methylprednisolone to address the pain. MRI on an unknown date with unknown results. The outcome of the event knee pain was unknown.  The consumer stated that the knee pain was unrelated to COVID vaccine.; Sender's Comments: The event Arthralgia is most likely related to an intercurrent or underlying condition which may not be related to the suspected drug BNT162B2.  Knee procedure may provide an explanation for the event.  The case will be reassessed if additional information becomes available.
pt recv vax 2MAY96 & 17MAY96 pt devel varicella-like rash consisting of 12 lesions;20MAY96 the number of lesions inc to 25;pt to MD w/o fever or other remarkable events;
Sunday, 1/24/21 arm started to itch.  Did scratch on it a little bit.  She then noticed it felt more like it itched, looked in the mirror and saw the rash line.  Originally it was just a sore arm at the site of vaccine.  2nd day the arm was sore, by noon on Monday everything was gone, and 5 days later now has the rash.  Rash area is 1 1/2" wide and 3" long in a line.  Really firm to touch where red parts to touch and feels a bit warm to the touch.  Has not touched it or bothered it since.  Today, her doctor has prescribed medications, but has not picked it up, antibiotic of some sort.
This spontaneous report was received from a nurse, and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and concomitant medications was provided. On 02-FEB-2018, the patient was vaccinated with an expired dose of M-M-R II (Lot # reported as L41456 with an expiration date in 22-OCT-2017), for prophylaxis (strength, route, dose and frequency were not provided). Concomitant therapies included sterile diluent (manufacturer unknown). No adverse effects reported and no product quality complaint (PQC) was involved. Lot number L41456 is an invalid lot number for M-M-R II.
About 4-6 minutes after receiving the vaccine my mouth got watery, after another minute I started to dry heeve for about 5 minutes.
C/O dull achy pain in left arm, noticed "divet" at this site 3-4 wks. after the vaccine was given. Saw MD on 12/2/11 Dr. measured the "divet" at 2 cm x 1.5 cm on client's left arm - feels due to vaccine - recommends arm be monitored every 2 months for 1 yr. Avoid taking flu vaccine in future. May need plastic surgery to fill in "divet" in future. Diag. muscle atrophy due to flu vaccine.
Big are like hives; Itchy at injection site; big red area below injection site; Area at injection site slightly raised; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Big are like hives), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE ERYTHEMA (big red area below injection site) and INJECTION SITE SWELLING (Area at injection site slightly raised) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy, Insomnia and Herpes NOS. Concomitant products included VALACYCLOVIR [VALACICLOVIR] for Herpes NOS, TRAZODONE for Insomnia.   On 06-Jan-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021 at 8:00 AM, the patient experienced URTICARIA (Big are like hives) and INJECTION SITE SWELLING (Area at injection site slightly raised). 14-Jan-2021 at 8:00 AM, the patient experienced INJECTION SITE PRURITUS (Itchy at injection site) and INJECTION SITE ERYTHEMA (big red area below injection site). On 17-Jan-2021, INJECTION SITE PRURITUS (Itchy at injection site) and INJECTION SITE ERYTHEMA (big red area below injection site) had resolved. At the time of the report, URTICARIA (Big are like hives) and INJECTION SITE SWELLING (Area at injection site slightly raised) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment of the events included, diphenhydramine   This case was linked to MOD-2021-086626 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up information was received on 22 Apr 2021 included, Race, ethnic group, height, weight of the patient.Current conditions and allergies were updated.Concomitant medications were reported.Event outcome was updated from recovering to resolved on 17 Jan 2021.second dose information added with the events. On 03-Jun-2021: No specific follow-up information recorded.
Left arm became sore immediately. I took ibuprofen 20 minutes after the injection. At 11pm I developed chills and a fever of 102. The fever continued throughout the night and all the following day. I used tylonel and Advil to help reduce the fever. In a 24 hour period from when I started symptoms, I slept for about 22 hours. Finally started feeling better on Wednesday around noon. I have no other major health concerns. My asthma is in check. I eat healthy and workout regularly.
Almost 7 month old, previously healthy male with 2 minute episode of altered level of consciousness in which eyes were rolled back and trunk was flexed. Infant staring straight ahead and not responsive. No tonic donic movements. Admitted to hospital 12/02/2001 for work up of new onset seizures. Pt not febrile. Positive 11 year old brother with history of febrile seizures. Hospitalized.
Traveler RN who received Moderna as first dose at another facility was here at Medical Center.  Instead of second dose Moderna, RN was injected with Pfizer.    No  negative clinical outcome observed.
pain @ inject site w/tingling down arm into fingers; started immed p/inject & cont past one month following inject; there is no swelling, redness or hardness @ site;
post-menopause spotting 2 days after second dose; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167), via an unspecified route of administration, administered in Arm Left on 05May2021 15:00 as dose 2, single for covid-19 immunization at an urgent care center. Medical history included hypertension from an unknown date, and post menopause from an unknown date with last period was 3-4 years prior. The patient was taking an unspecified hypertension medication. The patient was not diagnosed with covid-19 prior to vaccination and has not been tested since the vaccination. The patient previously received the first dose of bnt162b2 on an unspecified date at 52 years old for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07May2021, the patient experienced post-menopause spotting 2 days after second dose. No treatment was given. The reporter considered the event as serious, however, the event did not result in death or life threatening condition, caused or prolonged hospitalization, or disability. The outcome of the event was reported as recovered.
This spontaneous report was received from a registered nurse concerning an unspecified number of patients of 9 patients (demographics unknown). On 08-AUG-2014, the patients received improperly stored VARIVAX (Merck) (dose, lot number, expiration date and route were not provided). No adverse symptoms were reported. The temperature excursion for the VARIVAX (Merck) was supported with in-house stability data. This is one of several reports received from the same reporter. Additional information has been requested.
Site: Bruising at Injection Site-Severe, Site: Redness at Injection Site-Medium
bruising at the injection site; rash; noticed approximately 3-5 lesions; the injection hurt during the injection/then she felt a burning and muscle ache sensations in the arm afterwards; This spontaneous report was received from a 52-year-old female patient, referring to herself.  The patient's medical history was not reported. The patient's concurrent conditions included asthma, hypertension, hypersensitivity and sulfonamide allergy, she experienced a metallic taste in her mouth. Historical drugs included sulfa medication. Concomitant medications included, montelukast, amlodipine, loratadine (CLARITIN) and Covid-19 vaccine.   On 31-MAR-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, administered subcutaneously in the left upper arm for prophylaxis (strength, lot #, and expiry date were not provided). The patient said she was vaccinated because she has never had chicken pox or shingles and she did not have antibodies.  On the same date, the patient had a reaction at the injection site on her left (L) upper arm, the injection hurt during the injection and then she felt a burning and muscle ache sensations in the arm afterwards. On 15-APR-2023 (reported as last Saturday), she was hurting and looked in the mirror and noticed approximately 3-5 lesions, rash, and what appeared to be bruising at the injection site (L upper arm). The patient stated that she thought maybe she had slept on her neck wrong and that was possibly contributing to the pain but was unsure. She reported that the symptoms worsened and then within 2-3 days the symptoms began to improve, and she was currently recovering from al the events.  The causal relationship between the events and varicella virus vaccine live (oka/merck) (VARIVAX) was not reported.
Felt absolutely horrible! No appetite - lost 12 lbs in 14 days. Flat on my back for 2 weeks. Could only drink GatorAid & water. Drive myself to the doctor each week & had to lay down when I got there. Had to call 911 - my vitals were good so they wouldn't do anything for me. Being in the medical field, I knew I needed oxy & fluids. I was sick for another week. This vaccine was a joke! It was a money maker for the drug companies and could have bankrupt our county! It goes to prove that our government can not be trusted, now the CDC! The shut down of our county has affected people in negative ways, as had the vaccine. People have died because of it and others have long lasting affects! I wish I had NEVER taken it. I can't stand to even begin to get hot - I feel like my insides are on fire. I have headaches & can't smell or taste anymore. I thought I was going to die the 2 weeks I had covid, after receiving the vaccine 5 days before onset. Still couldn't take a deep for 4 more weeks, and had longhaulers exhaustion for 6 months. I still can't work like I use to, especially outside. I get tired easily and my joints ache all the time.
2/18/21 chest soreness, shortness of breath.   2/19/21 chest soreness, tired body aches, shortness of breath increased slightly.   Continued for 3 days.  2/23/21 seen Dr  extreme shortness of breath, chest pain, body aches, headaches, extreme tiredness. Blood work, chest X-ray, ekg ordered and completed that same day.   2/25/21 seen at clinic increase in symptoms, COVID test completed.  Evening of 2/25/21 went into a-fib hospitalized for 3 days.
After pt received dose of vaccine he remained seated. Mother alerted us that he was having side effects. She said his eyes closed and his head tilted back briefly. Pt's eyes were then open and he was alert, but pale. He stated no other symptoms. He put his head between his knees and applied a cold compress to back of neck. After a few minutes, he seemed stable enough to leave with mother.
Right arm swollen, red upper arm - down to the elbow. Pt received antibiotic for it on 9-27-13. Resolved in 3 days.
My child was fine after the 15 minute wait time. By 12pm on 1/25/2022; facial hives started. By 1/26/2022; hives had moved to his torso, both hands, and back. Child was treated with antihistamines. The healthcare provider was notified and we are communicating with them. Child had no previous history of any known allergies. Nothing new was introduced to the child?s environment or diet prior to vaccination.